MedTrace Logo

Fast Ultra Low Dose CT Interpretation

NCT05748184 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 4

Last updated 2023-08-29

No results posted yet for this study

Summary

An ultra-low-dose CT(ULDCT) image viewer prototype was developed in an iterative fashion that aims to reduce average interpretation times of ULDCT images. Ultimately, by reducing reading time of ULDCTs, we aim to enable general replacement of X-ray by ULDCT imaging, which is theorized to have large population-level health outcome impact in terms of early detection of lung cancer, coronary calcification, and aortic aneurysm, among others.

Conditions

  • Ultra-low-dose CT
  • Thoracic

Interventions

DEVICE

ULDCT PACS prototype

The ULDCT viewer prototype is a non-medical unreleased device that will be used by study participants on de-identified image cases in a research setting. The Prototype integrates new tools to speed up the diagnostic interpretation process of radiological images.

DEVICE

PACS viewer prototype

A PACS system mimicking the clinical PACS system used in LUMC.

DEVICE

Optimized ULDCT viewer prototype version(s)

The ULDCT viewer prototype is a non-medical unreleased device that will be used by study participants on de-identified image cases in a research setting. The Prototype integrates new tools to speed up the diagnostic interpretation process of radiological images. Optimized version(s) of previous version.

Sponsors & Collaborators

  • Leiden University Medical Center

    collaborator OTHER

  • Philips Electronics Nederland B.V. acting through Philips CTO organization

    lead INDUSTRY

Principal Investigators

  • Hildo Lamb, Prof. Dr. · Leiden University Medical Center

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-02-07
Primary Completion
2023-04-13
Completion
2023-08-24

Countries

  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05748184 on ClinicalTrials.gov